Introduction: A breakthrough in targeted cancer therapy Researchers at the University of Massachusetts Amherst are advancing customizable protein platforms designed to precisely shred or repair cancer-causing proteins within malignant cells. This innovative approach aims to offer targeted therapies that minimize collateral damage to healthy cells, addressing a longstanding challenge in oncology. While the immediate focus…